Roger J. Pomerantz

Person

Chalfont, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Cellular targets for treatment of retroviral infection
- Patent number 7,736,848
- Issue date Jun 15, 2010
- Fox Chase Cancer Center
- Rene Daniel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Multimerization of HIV-1 Vif protein as a therapeutic target
- Patent number 7,498,138
- Issue date Mar 3, 2009
- Thomas Jefferson University
- Hui Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Multimerization of HIV-1 Vif protein as a therapeutic target
- Patent number 7,226,741
- Issue date Jun 5, 2007
- Thomas Jefferson University
- Hui Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Multimerization of HIV-1 Vif protein as a therapeutic target
- Patent number 6,653,443
- Issue date Nov 25, 2003
- Thomas Jefferson University
- Hui Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for providing a protein to a virion
- Patent number 6,541,002
- Issue date Apr 1, 2003
- Thomas Jefferson University
- Roger J. Pomerantz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for treating a human immunodeficiency virus infection
- Patent number 6,251,868
- Issue date Jun 26, 2001
- Teijin Limited
- Satoshi Kubota
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ribozyme-mediated gene replacement
- Patent number 6,077,705
- Issue date Jun 20, 2000
- Thomas Jefferson University
- Lingxun Duan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for increasing transduction efficiency of recombinant retrov...
- Patent number 5,763,242
- Issue date Jun 9, 1998
- Thomas Jefferson University
- Hui Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
In situ polymerase chain reaction
- Patent number 5,750,347
- Issue date May 12, 1998
- Thomas Jefferson University
- Omar Bagasra
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
In situ polymerase chain reaction
- Patent number 5,589,333
- Issue date Dec 31, 1996
- Thomas Jefferson University
- Omar Bagasra
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Cellular Targets for Treatment of Retroviral Infection
- Publication number 20110086423
- Publication date Apr 14, 2011
- Fox Chase Cancer Center
- Rene Daniel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Multimerization of HIV-1 vif protein as a therapeutic target
- Publication number 20080167199
- Publication date Jul 10, 2008
- Thomas Jafferson University
- Hui Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cellular targets for treatment of retroviral infection
- Publication number 20060024694
- Publication date Feb 2, 2006
- Rene Daniel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Multimerization of HIV-1 Vif protein as a therapeutic target
- Publication number 20040146522
- Publication date Jul 29, 2004
- Hui Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Multimerization of HIV-1 VIF protein as a therapeutic target
- Publication number 20040086512
- Publication date May 6, 2004
- Thomas Jefferson University
- Hui Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Recombinant Rhabdoviruses as live-viral vaccines
- Publication number 20030124146
- Publication date Jul 3, 2003
- Matthias J. Schnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Recombinant rhabdoviruses as live-viral vaccines
- Publication number 20030091590
- Publication date May 15, 2003
- Roger J. Pomerantz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR PROVIDING A PROTEIN TO A VIRION
- Publication number 20030059765
- Publication date Mar 27, 2003
- ROGER J. POMERANTZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Multimerization of HIV-1 Vif protein as a therapeutic target
- Publication number 20030013844
- Publication date Jan 16, 2003
- Hui Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method of treating residual HIV-I disease
- Publication number 20020048584
- Publication date Apr 25, 2002
- Roger J. Pomerantz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Roger J. Pomerantz

Person

Patents Grantslast 30 patents

Cellular targets for treatment of retroviral infection

Multimerization of HIV-1 Vif protein as a therapeutic target

Multimerization of HIV-1 Vif protein as a therapeutic target

Multimerization of HIV-1 Vif protein as a therapeutic target

Compositions and methods for providing a protein to a virion

Method for treating a human immunodeficiency virus infection

Ribozyme-mediated gene replacement

Method for increasing transduction efficiency of recombinant retrov...

In situ polymerase chain reaction

In situ polymerase chain reaction

Patents Applicationslast 30 patents

Cellular Targets for Treatment of Retroviral Infection

Multimerization of HIV-1 vif protein as a therapeutic target

Cellular targets for treatment of retroviral infection

Multimerization of HIV-1 Vif protein as a therapeutic target

Multimerization of HIV-1 VIF protein as a therapeutic target

Recombinant Rhabdoviruses as live-viral vaccines

Recombinant rhabdoviruses as live-viral vaccines

COMPOSITIONS AND METHODS FOR PROVIDING A PROTEIN TO A VIRION

Multimerization of HIV-1 Vif protein as a therapeutic target

Method of treating residual HIV-I disease